A trial by Seattle-based Immusoft, a biotech company, said it is the first to genetically engineer B cells and test them in a patient, Wired reported Dec. 15.
Read the full post on Becker's Hospital Review - Healthcare News
A world first: Researchers test genetically engineered B cells in patient
